Synthesis of free radical polymerizable ethylenically unsaturated poloxamers and poloxamines

US9309357B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9309357-B2
Application numberUS-201414308229-A
CountryUS
Kind codeB2
Filing dateJun 18, 2014
Priority dateJun 18, 2013
Publication dateApr 12, 2016
Grant dateApr 12, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A new synthetic method of forming free radical polymerizable end terminal functionalized poloxamers and poloxamines in commercial scale batches which uses a binary system of inhibitors to eliminate the formation of high molecular weight impurities. It has also been surprisingly discovered that the inorganic impurities formed during the commercial scale synthetic process are removed by the use of resin materials.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising reacting a poloxamer or poloxamine compound with a first methacrylating agent in the presence of a solvent stabilized with a first free radical inhibitor to form a first reaction product, and further reacting the first reaction product with an organic base and a second methacrylating agent stabilized with a second free radical inhibitor to form a second reaction product, wherein the second free radical inhibitor is hydroquinone monomethyl ether (MEHQ), and wherein the first free radical inhibitor is a different compound than the second free radical inhibitor. 2. The method of claim 1 wherein the first and second methacrylating agents are the same. 3. The method of claim 2 wherein the methacrylating agent is methacryloyl chloride. 4. The method of claim 3 wherein the first free radical inhibitor is 2,6 di tert-butyl-4-methyl phenol (BHT). 5. The method of claim 4 wherein the organic base is triethylamine (TEA). 6. The method of claim 1 wherein the first free radical inhibitor is 2,6 ditert-butyl-4-methyl phenol (BHT). 7. The method of claim 1 wherein the organic base is triethylamine (TEA). 8. The method of claim 1 wherein the poloxamer or poloxamine compound is a poloxamer compound, wherein the first reaction product is a monomethacrylated poloxamer compound and wherein the second reaction product is a dimethacrylated poloxamer compound. 9. The method of claim 5 wherein the poloxamer or poloxamine compound is reacted with the first methacrylating agent in the presence of the organic base. 10. The method of claim 1 wherein the poloxamer or poloxamine compound is a poloxamine compound, wherein the first reaction product is a monomethacrylated poloxamine compound and wherein the second reaction product is a polymethacrylated poloxamine compound. 11. The method of claim 10 wherein the first and second methacrylating agents are methacryloyl chloride, and the first free radical inhibitor is 2,6 di tert-butyl-4-methyl phenol (BHT). 12. The method of claim 11 wherein the organic base is triethylamine (TEA). 13. The method of claim 12 wherein the poloxamine compound is reacted with the first methacrylating agent in the presence of the organic base. 14. The method of claim 1 wherein the poloxamer or poloxamine compound is reacted with the first methacrylating agent in the presence of the organic base. 15. A method comprising reacting a monomethacrylated poloxamer or monomethacrylated poloxamine compound with an organic base and a methacrylating agent stabilized with a hydroquinone monomethyl ether (MEHQ) free radical inhibitor to form a dimethacrylated poloxamer compound or a polymethacrylated poloxamine compound. 16. The method of claim 15 , wherein the monomethacrylated poloxamer compound is reacted with an organic base and a methacrylating agent stabilized with a hydroquinone monomethyl ether (MEHQ) free radical inhibitor to form a dimethacrylated poloxamer compound. 17. The method of claim 15 , wherein the monomethacrylated poloxamine compound is reacted with an organic base and a methacrylating agent stabilized with a hydroquinone monomethyl ether (MEHQ) free radical inhibitor to form a polymethacrylated poloxamine compound. 18. A reaction mixture comprising a monomethacrylated poloxamer or monomethacrylated poloxamine compound, an organic base, a methacrylating agent, and a hydroquinone monomethyl ether (MEHQ) free radical inhibitor. 19. The reaction mixture of claim 18 , wherein the monomethacrylated poloxamer or monomethacrylated poloxamine compound comprises a monomethacrylated poloxamer compound. 20. The reaction mixture of claim 18 , wherein the monomethacrylated poloxamer or monomethacrylated poloxamine compound comprises a monomethacrylated poloxamine compound.

Assignees

Inventors

Classifications

  • acyclic · CPC title

  • containing other elements (organic compounds containing halogens only as halides of a carboxyl group C08G65/332) · CPC title

  • C08G65/48Primary

    Polymers modified by chemical after-treatment · CPC title

  • Polyethers · CPC title

  • of polyhydric alcohols or polyhydric phenols · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9309357B2 cover?
A new synthetic method of forming free radical polymerizable end terminal functionalized poloxamers and poloxamines in commercial scale batches which uses a binary system of inhibitors to eliminate the formation of high molecular weight impurities. It has also been surprisingly discovered that the inorganic impurities formed during the commercial scale synthetic process are removed by the use o…
Who is the assignee on this patent?
Bausch & Lomb
What technology area does this patent fall under?
Primary CPC classification C08G65/48. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).